Home › Skin Conditions › California › Los Angeles
Skin Conditions clinical trials in Los Angeles, CA
4 studies for Skin Conditions are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis
RecruitingPhase 2
- UCLA Medical Center, Los Angeles
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
RecruitingPhase 3
- Dermatology Research Associates, Los Angeles
A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Metropolis Dermatology, Los Angeles
- Dermatology Research Associates, Los Angeles
- University of California Los Angeles, Los Angeles
A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Inmagene Site 23, Los Angeles
About Skin Conditions
Your skin is your body's largest organ. It covers and protects your body. Learn about skin conditions, including causes, symptoms, and treatment.
More about Skin Conditions on MedlinePlus
Skin Conditions trials in other cities
- Phoenix, AZ4 studies
- Portland, OR4 studies
- Indianapolis, IN4 studies
- Hollywood, FL4 studies
- Boston, MA3 studies
- Saint Joseph, MO3 studies
- Minneapolis, MN3 studies
- Arlington Heights, IL3 studies
- Tampa, FL3 studies
- Fargo, ND3 studies
- New York City, NY3 studies
- Santa Clarita, CA3 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)74 studies
- Breast Cancer73 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.